EU moves to unify science

Europe must invest more money and create better infrastructure to support science in order to remain globally competitive, said an independent panel of scientists advising the European Union in a linkurl:report;http://europa.eu/rapid/pressReleasesAction.do?reference=IP/09/1424&format=HTML&aged=0&language=EN&guiLanguage=en released today (October 6). Image: WikimediaThe group, called the European Research Area Board (ERAB), pointed out that Europe spends only 1% of its GDP on research, in compar

Written byEdyta Zielinska
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share
Europe must invest more money and create better infrastructure to support science in order to remain globally competitive, said an independent panel of scientists advising the European Union in a linkurl:report;http://europa.eu/rapid/pressReleasesAction.do?reference=IP/09/1424&format=HTML&aged=0&language=EN&guiLanguage=en released today (October 6).
Image: Wikimedia
The group, called the European Research Area Board (ERAB), pointed out that Europe spends only 1% of its GDP on research, in comparison with 1.69% in the US and 2.62% in Japan. And although European researchers produce a third of all research papers world-wide, research published in the US is more highly cited. In today's report, the board proposed six strategies to unify and strengthen science in Europe -- from improving mobility of scientists to promoting scientific excellence over nationalism. The ERA initiative was created in 2000 to provide a unified structure for science, but efforts to integrate research across nations soon stalled. Last year, the European Commission assembled 22 academic, non-profit, and industry scientists from different countries to advise the Commission on how to focus its efforts. "Many of us have a very firm intention to realize [the recommendations] as fast as possible," Norbert Kroo, vice president of the Hungarian Academy of Sciences and a board member of the European Research Council, told The Scientist. He added, though, that the global economic crisis might slow the process. Some of the ERAB's recommendations have already been promised by European leaders. Last month, upon being sworn in for his second term as president of the European Commission (EC), Jose Manuel Barroso said that he would promote the creation of a new position, a chief scientific officer of Europe, who would represent European science and advise the EC. The ERAB document, too, makes this suggestion; European science "should be represented by one single voice," said Kroo. Broadly, the aim of the ERAB recommendations is to create "a more cohesive society from a research perspective," said John Wood, chair of the ERAB and a professor of engineering at Imperial College London -- to "use all the brains we've got." The report outlines six major themes to accomplish that goal: creating a unified research strategy; focusing research on societal needs such as sustainable energy and healthcare; increasing the interaction between science and policy, and between academia and industry; and promoting cohesion as well as excellence among European researchers. To make Europe more competitive for global innovation, the board recommended simplifying and unifying intellectual property laws and patent procedures, which currently vary across all member nations. "We find people from China come here, and they don't want to talk to 27 different [nations]" of the European Union, said Wood. The board also suggested taking steps to increase mobility for European scientists across institutions and borders. "In the Cold War, national security was the priority," said Kroo. "Countries very carefully guarded their research to keep it within their borders. Now, the priorities are competition and job creation," which require greater collaboration among EU nations. The problem of simplifying scientists' mobility, however, is "a tricky one," said Wood, as it can be impossible for researchers to keep their retirement savings when moving to linkurl:another country.;http://www.the-scientist.com/blog/display/55897/ Some recommendations, for example ensuring that by 2030 "half of all scientist and research policy makers, across all disciplines and at all levels of the science system, are women," do not include specifics about how the goals might be met. In the coming weeks and months, however, the ERAB plans develop concrete proposals on just how the European Union can deliver on those goals, said Wood. The ERAB's proposals will eventually be discussed in European parliament. However, Kroo said, member nations don't have to wait for the EU to begin implementing the recommendations. "There is an article in the treaty of Rome" -- one of the treaties that was the basis of the European Union -- "article 169, which makes it possible for member countries to create consortia" around particular initiatives . An often-quoted example is that of the particle accelerator project, CERN, which was built with support from multiple nations. But it may not be easy -- although there are precedents for country collaboration, said Kroo, "there are some legal obstacles" which make the process more cumbersome than is necessary.
**__Related stories:__***linkurl:Pensions for postdocs;http://www.the-scientist.com/blog/display/55897/
[19th August 2009]*linkurl:ERC launched today;http://www.the-scientist.com/news/display/52908/
[27th February 2007]*linkurl:Plan to double EU research spending;http://www.the-scientist.com/news/20050408/02/
[8th April 2005]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies